(Reuters) - U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of ...
Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback